Dr. Joseph McGuirk, MD
Claim this profileThe University of Kansas Hospital
Affiliated Hospitals
The University Of Kansas Hospital
University Of Kansas Medical Center Research Institute Inc
Clinical Trials Joseph McGuirk, MD is currently running
Umbilical Cord Stem Cells
for Graft-versus-Host Disease
This study evaluates the safety and effectiveness of two different doses of umbilical cord derived, ex-vivo cultured and expanded Wharton's jelly mesenchymal stem cells (MSCTC-0010) in the treatment of acute Graft versus Host Disease (aGVHD). The first 5 participants enrolled in the study will receive a lower dose of MSCTC-0010. If none of the first 5 participants have treatment-related serious adverse events (TRSAEs) for 42 days, then the next 5 participants will receive a slightly higher dose of MSCTC-0010.
Recruiting
1 award
Phase 1
11 criteria
OrcaGraft
for Blood Cancer
This trial is testing the safety and effectiveness of using specially prepared donor cells for patients with blood cancers. These patients are receiving a strong type of bone marrow transplant. The goal is to replace their damaged bone marrow with healthy cells from a donor to help them recover. Bone marrow transplantation (BMT) is a powerful strategy for the treatment of leukemia, aplastic anemia, congenital immunodeficiency, and autoimmune diseases.
Recruiting
1 award
Phase 1
More about Joseph McGuirk, MD
Clinical Trial Related
6 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments Joseph McGuirk, MD has experience with
- MSCTC-0010
- Orca-T
- CRG-022
- CTX110
- AUTO1
- EAGD T-cell Infusion
Breakdown of trials Joseph McGuirk, MD has run
Acute Myelogenous Leukemia
Myelodysplastic Syndrome
Acute Lymphoblastic Leukemia
Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Joseph McGuirk, MD specialize in?
Joseph McGuirk, MD focuses on Acute Myelogenous Leukemia and Myelodysplastic Syndrome. In particular, much of their work with Acute Myelogenous Leukemia has involved treating patients, or patients who are undergoing treatment.
Is Joseph McGuirk, MD currently recruiting for clinical trials?
Yes, Joseph McGuirk, MD is currently recruiting for 3 clinical trials in Kansas City Kansas. If you're interested in participating, you should apply.
Are there any treatments that Joseph McGuirk, MD has studied deeply?
Yes, Joseph McGuirk, MD has studied treatments such as MSCTC-0010, Orca-T, CRG-022.
What is the best way to schedule an appointment with Joseph McGuirk, MD?
Apply for one of the trials that Joseph McGuirk, MD is conducting.
What is the office address of Joseph McGuirk, MD?
The office of Joseph McGuirk, MD is located at: The University of Kansas Hospital, Kansas City, Kansas 66160 United States. This is the address for their practice at the The University of Kansas Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.